Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Solifenacin manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : Argentina

Clear all

4 products found

solifenacin

Tablets 5mg, 10mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Manufacturer #16247
The pharmaceutical company is currently in 120+ presentations corresponding to 50+ products that cover common clinical conditions, attended by a wide range of specialties. In Oncology and Special Treatments Line, which already has more than 3 products in more than 5 presentations, also venturing into the field of Pulmonology through a new Respiratory Line.

Manufacturer usually replies in 3 days

solifenacin

Tablets 5 mg, 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17885
The company was established in the initial of 1930s. The company’s mission is to develop and elaborate medicinal specialties of high quality and efficacy to offer trustworthy therapeutic alternatives to health professionals; in short, to offer the national and international medical community, medicines of excellence and quality

Manufacturer usually replies in 10 days

solifenacin

Tablets, film coated 5mg, 10mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina
Available for
Distribution only
Manufacturer #16240
It is a laboratory that produces several product lines, such as allergy, cardiology, clinic, dermatology, gastroenterology, geriatrics, neurology, pediatrics, psychiatry, and urology, among others.

Manufacturer usually replies in 6 days

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

SOLIFENACIN

Solifenacin is an antimuscarinic medication. It treats overactive bladder, a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination. Solifenacin is also used to treat neurogenic detrusor overactivity, a condition in which a bladder control condition caused by a brain, spinal cord or nerve problem in children 2 years of age and older. Solifenacin is called an antimuscarinic, they work by relaxing the bladder muscles.
Solifenacin is sold under the brand name Vesicare among others. Yamanouchi Pharma America, Inc studied the compound using animal models in the early 2000s. Solifenacin was first approved for sale in the United States in 2004 with an indication to treat overactive bladder in adults older than 18 years. In May 2020, FDA to treat neurogenic detrusor overactivity (NDO), a form of bladder dysfunction related to neurological impairment, in children ages two years and older, approved Solifenacin.

Forms and dosage:

The Usual Adult Dose recommended for treating Urinary Incontinence is an initial dose of 5 mg, orally, once daily. This is followed by a maintenance dose of 5 to 10 mg, taken orally, once a day. For treating overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency, the usual adult dose starts with 5 mg, followed by a maintenance dose of 5 to 10 mg, taken orally, once daily.

The cost of Solifenacin

As of 2019, consumers in the United Kingdom paid about £27.62 for a month's supply. However, this is significantly higher in the United States, with the cost of the same supply is about US$370.

How does it work?

Its action improves the ability of the patient to control urination by relaxing the muscles in the bladder. It also reduces leaking of urine, urges to urinate urgently and reduces the frequency of trips to the washroom. To elaborate, it works as a competitive cholinergic receptor antagonist, selective for the M3 receptor subtype. When acetylcholine binds to these receptors, particularly M3, it makes contraction of smooth muscle possible. This medicine prevents the binding of acetylcholine to these receptors, thus reducing the smooth muscle tone in the bladder. The overall effects of the activity increase the bladder’s ability to retain larger volumes of urine and reducing the number of micturition, urgency and incontinence episodes.

Finding Solifenacin Manufacturers and Suppliers:

The process of finding trusted Solifenacin manufacturers and Solifenacin suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. Also, it is an easy to use online platform to grow your business opportunities.
The robust search engine makes it convenient to search for manufacturers and suppliers of Solifenacin. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation